Profusa

PFSA
1.4204.70% ( -0.070 )
Closed: Oct 9, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -0.02, above the reasonable range, cheaper than 15.71% of the time in the past 1 years, and the industry ranks 49/174, the industry Median -0.89.

-0.021xP/E
Stock price$1.49Earnings per share$-70.94

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BAXUSBaxter
-11.62x141.71%$12.36B
GKOSUSGlaukos
-50.59x75.37%$9.51B
TFXUSTeleflex
-5.10x118.39%$5.26B
PLSEUSPulse Biosciences
-44.53x27.55%$3.56B
IRTCUSIRhythm
-242.49x70.88%$3.38B
BFLYUSButterfly Network
-28.57x34.41%$2.14B
AXGNUSAxogen
-63.27x18.38%$2.12B
ASSTUSStrive
-2.00x63.23%$1.95B
NVCRUSNovocure
-11.15x1.23%$1.66B
ATECUSAlphatec
-14.53x41.67%$1.60B
KMTSUSKestra Medical Tech
-10.08x0.94%$1.51B
DRTSUSAlpha Tau Medical
-13.96x--$1.29B
TNDMUSTandem Diabetes
-17.23x77.60%$1.09B
IARTUSIntegra LifeSciences
-144.11x109.42%$1.04B
AORTUSArtivion
-324.07x266.67%$1.03B
PRCTUSPROCEPT BioRobotics
-9.34x3.47%$1.03B
ENOVUSEnovis
-0.91x100.97%$1.01B
BBNXUSBeta Bionics
-12.57x11.66%$917.55M
CBLLUSCeribell
-13.46x35.15%$888.45M
QDELUSQuidelOrtho
-0.81x75.33%$851.02M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.